Casdin Capital, LLC Biolife Solutions Inc Transaction History
Casdin Capital, LLC
- $713 Million
- Q2 2025
A detailed history of Casdin Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Casdin Capital, LLC holds 7,707,165 shares of BLFS stock, worth $185 Million. This represents 23.27% of its overall portfolio holdings.
Number of Shares
7,707,165
Previous 8,707,165
11.48%
Holding current value
$185 Million
Previous $199 Million
16.52%
% of portfolio
23.27%
Previous 23.27%
Shares
14 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$102 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$86.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$69.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.41MShares$33.9 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...